Eli Lilly and Camurus have entered into partnership worth up to $870m to develop long-acting therapies in cardiometabolic ...

That word ‘creativity’ can make our eyes roll, light up, or widen in panic, depending on our mood and workload. Thanks to new ...

AstraZeneca (AZ) has announced that its fixed-duration Calquence (acalabrutinib)-based regimens have been approved by the ...

I also miss the immersive nature of in-person events – no distractions and no clinical responsibilities, just dedicated time ...

VML Health has announced the appointment of Nick Bartlett as chief executive officer of its EU hub. Bartlett holds over 20 ...

The value of AI in healthcare communications lies in its ability to understand what motivates, frustrates and resonates with ...

This constant barrage of new and varied challenges necessitates that medical affairs teams evaluate and communicate the ...

Explore how Cuttsy+Cuttsy and ISPEP are spotlighting patient engagement in clinical trials through a new global report.

Roche’s Evrysdi (risdiplam) tablets have been approved by the European Commission (EC) to treat spinal muscular atrophy (SMA) ...

Regeneron Pharmaceuticals has announced that it will be gaining rights to Hansoh Pharmaceuticals’ investigational dual ...

At HCG, our goal is medical education that helps HCPs meet their patients where they are. Our commercial and marketing ...

Dive into 2025's cutting-edge medical education technologies like immersive training, interactive data visualization, and ...